Why are drug prices so high? Investigating th...

We all have a "thing" — the way we act when we're not at our best that we somehow can't see in ourselves. Leadership expert Chris Wheatley learned about his when his best friend at work called him on it. He shares how hearing that hard truth shattered a lifelong pattern of defens ...  Show more

Did progress on your next big project stall out? Transformation expert Mary Martin refers to this moment as the "messy middle" — the frustrating gap between starting and finishing a goal, when you might lose confidence or give up altogether. Offering three ways to find glimmers o ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. The Pharmaceutical industry ...  Show more